Sign inJoin waitlistJoin the waitlist

Lilja Solnes

Vice Chair, At Large · University of Texas Southwestern Medical Center

Credentials: · · · · · · · ·

History

At Large · University of Texas Southwestern Medical Center
Present
University of Texas Southwestern Medical Center
Present

Neuroradiology
Ohio State University Hospital
2005–2006
Diagnostic Radiology
New York Presbyterian Hospital
2003–2005
Nuclear Medicine
2000–2003
Internal Medicine
Albert Einstein Medical Center
1998–2001
Columbia Univ Coll of Phys & Surgeons
1996–2000

Research

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Review · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 257 citations
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Journal of Nuclear Medicine · 2019 · 235 citations
Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
Neurology · 2017 · 135 citations

Steven Rowe
87 papers · 64 as a fellow
SS
Sara Sheikhbahaei
40 papers · 39 as a resident
Martin Pomper
37 papers
MJ
Mehrbod Javadi
33 papers
MG
Michael Gorin
32 papers · 11 as a resident
Andrei Gafita
15 papers · 15 as a resident
Jorge Oldan
15 papers
Mohammed Allaf
14 papers
Kenneth Pienta
13 papers
Moe Sadaghiani
13 papers · 13 as a resident
Prasanna Santhanam
13 papers
Andrew Voter
11 papers · 11 as a resident

Grants

Resource for Molecular Imaging Agents in Precision Medicine
National Institute of Biomedical Imaging and Bioengineering · P41
Project lead · $168.6K · Ut Southwestern Medical Center
2017–2029
Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy
National Cancer Institute · U01
PI · $2.8M · Johns Hopkins University
2011–2024

Clinical trials

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
Principal investigator · Terminated · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2019–2022
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Principal investigator · Unknown · Phase 2
Molecular Insight Pharmaceuticals, Inc.
2009–2021